These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 18690346

  • 1. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
    Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S.
    Thromb Haemost; 2008 Aug; 100(2):261-70. PubMed ID: 18690346
    [Abstract] [Full Text] [Related]

  • 2. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
    Manolopoulos P, Glenn JR, Fox SC, May JA, Dovlatova NL, Tang SW, Thomas NR, Ralevic V, Heptinstall S.
    Platelets; 2008 Mar; 19(2):134-45. PubMed ID: 18297551
    [Abstract] [Full Text] [Related]

  • 3. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
    Heptinstall S, Espinosa DI, Manolopoulos P, Glenn JR, White AE, Johnson A, Dovlatova N, Fox SC, May JA, Hermann D, Magnusson O, Stefansson K, Hartman D, Gurney M.
    Platelets; 2008 Dec; 19(8):605-13. PubMed ID: 19012178
    [Abstract] [Full Text] [Related]

  • 4. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A, Cerletti C, de Gaetano G.
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [Abstract] [Full Text] [Related]

  • 5. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
    Judge HM, Buckland RJ, Sugidachi A, Jakubowski JA, Storey RF.
    Platelets; 2008 Mar; 19(2):125-33. PubMed ID: 18297550
    [Abstract] [Full Text] [Related]

  • 6. Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
    Kobsar AL, Koessler J, Rajkovic MS, Brunner KP, Steigerwald U, Walter U.
    Platelets; 2010 Mar; 21(2):112-6. PubMed ID: 20085435
    [Abstract] [Full Text] [Related]

  • 7. Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.
    Iyú D, Glenn JR, White AE, Fox SC, van Giezen H, Nylander S, Heptinstall S.
    Thromb Haemost; 2011 Jan; 105(1):96-106. PubMed ID: 20941457
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
    Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ.
    Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
    [Abstract] [Full Text] [Related]

  • 9. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
    Maayani S, Schwarz TE, Patel ND, Craddock-Royal BD, Tagliente TM.
    Platelets; 2003 Jan; 14(7-8):445-62. PubMed ID: 14713514
    [Abstract] [Full Text] [Related]

  • 10. P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
    Iyú D, Glenn JR, White AE, Fox SC, Dovlatova N, Heptinstall S.
    Platelets; 2011 Jan; 22(7):504-15. PubMed ID: 21591981
    [Abstract] [Full Text] [Related]

  • 11. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
    Baurand A, Eckly A, Bari N, Léon C, Hechler B, Cazenave JP, Gachet C.
    Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
    [Abstract] [Full Text] [Related]

  • 12. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 13. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
    Mateos-Trigos G, Evans RJ, Heath MF.
    Platelets; 2002 Mar; 13(5-6):285-92. PubMed ID: 12189014
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
    Petrucci G, De Cristofaro R, Rutella S, Ranelletti FO, Pocaterra D, Lancellotti S, Habib A, Patrono C, Rocca B.
    J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
    [Abstract] [Full Text] [Related]

  • 15. PGE(2) reverses G(s)-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G(s)-mediated inhibition of platelet aggregation by interaction with EP4 receptors.
    Glenn JR, White AE, Iyu D, Heptinstall S.
    Platelets; 2012 Feb; 23(5):344-51. PubMed ID: 22436052
    [Abstract] [Full Text] [Related]

  • 16. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.
    Iyú D, Glenn JR, White AE, Fox SC, Heptinstall S.
    Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):416-22. PubMed ID: 21106949
    [Abstract] [Full Text] [Related]

  • 17. Cangrelor attenuates coated-platelet formation.
    Norgard NB, Hann CL, Dale GL.
    Clin Appl Thromb Hemost; 2009 Feb; 15(2):177-82. PubMed ID: 18796456
    [Abstract] [Full Text] [Related]

  • 18. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF, Newby LJ, Heptinstall S.
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [Abstract] [Full Text] [Related]

  • 19. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M, Dickenson JM.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):166-73. PubMed ID: 16820147
    [Abstract] [Full Text] [Related]

  • 20. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
    Packham MA, Mustard JF.
    Semin Thromb Hemost; 2005 Apr 14; 31(2):129-38. PubMed ID: 15852216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.